BAY-1841788 is primarily utilized in research and development within the pharmaceutical industry, particularly in the study of cancer therapeutics. It functions as an inhibitor targeting specific enzymes or proteins involved in tumor growth and proliferation. Researchers employ this compound to investigate its efficacy in disrupting signaling pathways that contribute to cancer progression. Its application extends to preclinical studies, where it is tested in various cancer models to assess its potential as a targeted therapy. Additionally, BAY-1841788 is used to explore combination therapies, aiming to enhance the effectiveness of existing treatments or overcome drug resistance in cancer cells.